Migration, proliferation, and invasion of human glioma cells following treatment with simvastatin

Neurosurgical Review

Volumn 26, Issue 2, 2003, Pages 117-124

  Gliemroth, Jan ^a   Zulewski, Henryk ^b   Arnold, Hans ^a   Terzis, A Jorge A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Invasion; Malignant glioma; Simvastatin; Three dimensional culture

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN; CANCER INVASION; CELL INVASION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MIGRATION INHIBITION; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SPHEROID;

ANIMALS; BRAIN; CELL DIVISION; CELL MOVEMENT; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOMA; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NEOPLASM INVASIVENESS; RATS; RATS, WISTAR; SIMVASTATIN; SPHEROIDS, CELLULAR; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0038072673     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10143-003-0258-9     Document Type: Article

References (55)

1. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225
2. Andratschke N, Grosu AL, Molls M, Nieder C (2001) Perspectives in the treatment of malignant gliomas in adults. Anticancer Res 21:3541-3550
3. Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R, Porchet F, Regli L, de Tribolet N, Mirimanoff RO, Leyvraz S (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20:1375-1382
4. Kikuchi T, Nagata Y, Abe T (1997) In vitro and in vivo antiproliferative effects of simvastatin, an HMG-CoA reductase inhibitor, on human glioma cells. J Neurooncol 34:233-239
5. Langan TJ, Iimori Y, White G, Volpe JJ (1987) Regulation of sterol synthesis and of 3-hydroxy-3-methylglutaryl coenzyme a reductase by lipoproteins in glial cells in primary culture. J Neurosci Res 17:361-366
6. Fairbanks KP, Barbu VD, Witte LD, Weinstein IB, Goodman DS (1986) Effects of mevinolin and mevalonate on cell growth in several transformed cell lines. J Cell Physiol 127:216-222
7. Maltese WA, Sheridan KM (1985) Differentiation of neuro-blastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis. J Cell Physiol 125:540-558
8. Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425-430
9. Jones KD, Couldwell WT, Hinton DR, Su Y, He S, Anker L, Law RE (1994) Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem Biophys Res Comm 205:1681-1687
10. Newman A, Clutterbuck RD, Powles RL, Millar JL (1994) Selective inhibition of primary acute myeloid leukemia cell growth by simvastatin. Leukemia 8:2023-2029
11. Soma MR, Corsini A, Paoletti R (1992) Cholesterol and mevalonic acid modulation in cell metabolism and multiplication. Toxicol Lett 64/65:1-15
12. Soma MR, Baetta R, De Renzis MR, Mazzini G, Davegna C, Magrassi L, Butti G, Pezzotta S, Paoletti R, Fumagalli R (1995) In vivo enhanced antitumor activity of carmustine N,N'-bis(2-chloroethyl)-N-nitrosourea by simvastatin. Cancer Res 55:597-602
13. Sutherland RM, Freyer J, Mueller-Klieser W (1986) Cellular growth and metabolic adaptations to nutrient stress environments in tumour microregions. Int J Radiat Oncol Biol Phys 12:611-615
14. Sutherland RM (1988) Cell and environment interactions in tumour microregions: the multicellular spheroid model. Science 240:177-184
15. Akslen LA, Andersen KJ, Bjerkvig R (1988) Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res 8:797-804
16. Yuhas JM, Li AP, Martinez AO, Ladman AJ (1977) A simplified method for production and growth of multicellular spheroids. Cancer Res 37:3639-3643
17. Bjerkvig R, Steinvaag SK, Laerum OD (1986) Reaggregation of fetal rat brain cells in a stationary culture system. I. Methodology and cell identification. In Vitro Cell Dev Biol 22:180-192
18. Bjerkvig R (1986) Reaggregation of fetal rat brain cells in a stationary culture system. II. Ultrastructure characterisation. In Vitro Cell Dev Biol 22:193-200
19. Gundersen HJG, Jensen EB (1987) The efficiency of systematic sampling in stereology and its prediction. J Microscopy 147:229-263
20. Bjerkvig R, Høstmark J, Pedersen PH, Laerum OD (1992) Tumor spheroids from biopsy specimens. In: Bjerkvig R (ed) Spheroid culture in cancer research. CRC, Boca Raton, pp 41-56
21. Carlsson J, Nederman T (1992) Tumor spheroids as a model in studies of drug effects. In: Bjerkvig R (ed) Spheroid culture in cancer research. CRC, Boca Raton, pp 199-216
22. Buchwald H (1992) Cholesterol inhibition, cancer, and chemotherapy. Lancet 339:1154-1156
23. Chen HW, Kandutsch AA, Heiniger HJ (1978) The role of cholesterol in malignancy. Prog Exp Tumor Res 22:275-316
24. Friedman SJ, Bokesch H, Skehan P (1987) The regulation of sterol metabolism by cell interactions. Expl Cell Res 172:463-473
25. Yeagle PL (1988) Cholesterol and cell membrane. In: Yeagle PL (ed) Biology of cholesterol. CRC, Boca Raton, pp 121-146
26. Davidson AN (1965) Brain sterol metabolism. Adv Lipid Res 3:171-196
27. Kandutsch AA, Saucier SE (1969) Regulation of sterol synthesis in developing brains of normal and jimpy mice. Archs Biochem Biophys 135:201-208
28. Dahl C, Dahl J (1988) Cholesterol and cell function. In: Yeagle PL (ed) Biology of cholesterol. CRC, Boca Raton, pp 147-171
29. Fumagalli R, Grossi E, Paoletti P, Paoletti R (1964) Studies on lipids in brain tumors. Occurrence and significance of sterol precursors of cholesterol in human brain tumors. J Neurochem 11:561-565
30. Grieb P, Ryba MS, Jagielski J, Gackowski W, Paczkowski P, Chrapusta SJ (1999) Serum cholesterol in cerebral malignancies. J Neurooncol 41:175-180
31. Paoletti P, Soloway AH, Whitman B, Messer JR (1966) Lipid biosynthesis from labelled precursors in an experimental brain-tumor bearing mouse. Neurochirurgia 9:12-18
32. Volpe JJ (1979) Microtubules and the regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase. J Biol Chem 254:2568-2571
33. Habenicht AJR, Glomset JA, Ross R (1980) Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem 255:5134-5140
34. Maltese WA (1983) 3-Hydroxy-3-methylglutaryl coenzyme A reductase in human brain tumors. Neurology 33:1294-1299
35. Maltese WA, Sheridan KM (1988) Isoprenoid synthesis during the cell cycle. J Biol Chem 263:10104-10110
36. Maltese WA (1990) Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J 4:3319-3328
37. Prasanna P, Thibault A, Liu L, Samid D (1996) Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells. J Neurochem 66:710-716
38. Quesney-Huneeus V, Wiley MH, Siperstein MD (1979) Essential role for mevalonate synthesis in DNA replication. Proc Natl Acad Sci U S A 76:5056-5060
39. Quesney-Huneeus V, Galick HA, Siperstein MD, Erickson SK, Spencer TA, Nelson JA (1983) The dual role of mevalonate in the cell cycle. J Biol Chem 258:378-385
40. Jakobisiak M, Bruno S, Skiersk JS, Darzynkiewicz Z (1991) Cell cycle-specific effects of lovastatin. Proc Natl Acad Sci USA 88:3628-3632
41. Bouterfa HL, Sattelmeyer V, Czub S, Vordermark D, Roosen K, Tonn JC (2000) Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells. Anticancer Res 20:2761-2771
42. 4 cells in vitro. Arch Geschwulstforsch 51:45-50
43. Murakami M, Goto T, Saito Y, Goto S, Kochi M, Ushio Y (2001) The inhibitory effect of simvastatin on growth in malignant gliomas - with special reference to its local application with fibrin glue spray in vivo. Int J Oncol 19:525-531
44. Wang W, Macaulay RJ (1999) Mevalonate prevents lovastatin-induced apoptosis in medulloblastoma cell lines. Can J Neurol Sci 26:305-310
45. Pentikainen PJ, Saraheimo M, Schwartz JI, Amin RD, Schwartz MS, Brunner-Ferber F, Rogers JD (1992) Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans. J Clin Pharmacol 32:136-140
46. Vickers S, Duncan CA, Chen IW, Duggan DE (1990) Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug. Drug Metab Dispos 18:138-145
47. Kita T, Brown MS, Goldstein JL (1980) Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J Clin Invest 66:1094-1100
48. Mikulski SM. Viera A, Darzynkiewicz Z, Shogen K (1992) Synergism between a novel amphibian oocyte ribonuclease and lovastatin in inducing cytostatic and cytotoxic effects in human lung and pancreatic carcinoma cell lines. Br J Cancer 66:304-310
49. Soma MR, Pagliarini P, Butti G, Paoletti R, Paoletti P, Fumagalli R (1992) Simvastatin, an inhibitor of cholesterol biosynthesis, shows a synergistic effect with N,N'-bis(2-chloroethyl)-N-nitrosourea and β-interferon on human glioma cells. Cancer Res 52:4348-4355
50. Soma MR, Baetta R, Bergamaschi S, De Renzis MR, Davegna C, Battaini F, Fumagalli R, Govoni S (1994) PKC activity in rat C6 glioma cells: changes associated with cell cycle and simvastatin treatment. Biochem Biophys Res Comm 200:1143-1149
51. Engebraaten O, Bjerkvig R, Pedersen PH, Laerum OD (1993) Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro. Int J Cancer 53:209-214.
52. Mueller-Klieser WF, Freyer JP, Sutherland RM (1986) Influence of glucose and oxygen supply conditions on the oxygenation of multicellular spheroids. Br J Cancer 53:345-353
53. Sumi S, Beauchamp RD, Townsend Jr CM, Pour PM, Ishizuka J, Thompson JC (1994) Lovastatin inhibits pancreatic cancer growth regardless of ras mutation. Pancreas 9:657-661
54. Lamer J, Jane J, Laws E, Packer R, Myers C, Shaffrey M (1998) A phase 1-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme. Am J Clin Oncol 21:579-583
55. Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, Hohl RJ, Trepel J, Liang B, Patronas N, Venzon DJ, Reed E, Myers CE (1996) Phase 1 study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res 2:483-491